Emergence of secondary fusions in chronic myeloid leukemia as a driver of tyrosine kinase inhibitor resistance and blast crisis transformation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia research 2024-02, Vol.137, p.107439-107439, Article 107439
Hauptverfasser:	Boucher, Lara, Rozalska, Laura, Sorel, Nathalie, Olivier, Gaëlle, Hernanz, Maria Pilar Gallego, Cayssials, Emilie, Raimbault, Anna, Chomel, Jean-Claude
Format:	Artikel
Sprache:	eng
Schlagworte:	BCR::ABL1 Blast Crisis - drug therapy CML CML transformation Drug Resistance, Neoplasm - genetics Fusion Proteins, bcr-abl - genetics Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myeloid Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Secondary fusion TKI resistance Tyrosine Kinase Inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!